Sickle cell disease (SCD) is a monogenic disorder that afflicts approximately 100,000
Americans and millions of people worldwide. It is characterized by hemolytic anemia, vaso …

Background Vaso-occlusive pain crisis is one of the primary complications of sickle cell
disease (SCD) and is responsible for the majority of hospital visits in patients with SCD …

Sickle cell disease (SCD) is the most common inherited disease. Pain is a key morbidity of
SCD and opioids are the main treatment but their side effects emphasize the need for new …

Acute, intermittent vaso-occlusive pain is the hallmark of sickle cell disease (SCD) and is
associated with substantial morbidity and impaired quality of life (QOL). The subgroup of …

Objectives: The hallmark of sickle cell disease (SCD) is acute and chronic pain, and the pain
dominates the clinical characteristics of SCD patients. Although pharmacological treatments …

Background Sickle cell disease (SCD) is a group of inherited disorders of haemoglobin (Hb)
structure in a person who has inherited two mutant globin genes (one from each parent), at …

Among 170 adults with sickle cell disease, we evaluated chronic pain impact and disability
prevalence, assessed age and gender differences, and identified psychosocial predictors of …

Background Vaso-occlusive pain crises (VOCs) are the “hallmark” of sickle-cell disease
(SCD) and can lead to sympathetic nervous system dysfunction. Increased sympathetic …

Objective: To develop and validate a YM for SCD. Methodology: Concise literature reports
on yoga practices used for varied symptoms/comorbidities associated with SCD were …

Sickle cell disease (SCD) is one of the most common severe genetic diseases around the
world. A majority of SCD patients experience intense pain, leading to hospitalization, and …